Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Inventory (2016 - 2025)

Historic Inventory for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $65.6 million.

  • Angiodynamics' Inventory fell 52.94% to $65.6 million in Q4 2025 from the same period last year, while for Nov 2025 it was $65.6 million, marking a year-over-year decrease of 52.94%. This contributed to the annual value of $62.0 million for FY2025, which is 229.31% up from last year.
  • Angiodynamics' Inventory amounted to $65.6 million in Q4 2025, which was down 52.94% from $62.3 million recorded in Q3 2025.
  • Angiodynamics' 5-year Inventory high stood at $65.9 million for Q4 2024, and its period low was $48.0 million during Q1 2022.
  • For the 5-year period, Angiodynamics' Inventory averaged around $58.0 million, with its median value being $60.3 million (2023).
  • As far as peak fluctuations go, Angiodynamics' Inventory plummeted by 1884.82% in 2021, and later skyrocketed by 3225.09% in 2023.
  • Quarter analysis of 5 years shows Angiodynamics' Inventory stood at $48.2 million in 2021, then soared by 31.12% to $63.2 million in 2022, then increased by 1.7% to $64.3 million in 2023, then grew by 2.59% to $65.9 million in 2024, then decreased by 0.53% to $65.6 million in 2025.
  • Its Inventory stands at $65.6 million for Q4 2025, versus $62.3 million for Q3 2025 and $62.0 million for Q2 2025.